Antibacterial Effects of Azadirachta indica Leaf and Bark Extracts in Clinical Isolates of Diabetic Patients
Antibacterial activities of neem extracts on diabetic samples Antibacterial
Keywords:
Antibacterial activity, Azadirachta indica, bark extract, diabetes, leaf extractAbstract
Background: Antibacterial activities of crude Azadirachta indica (neem) bark and leaf extracts were investigated in bacterial species isolated from clinical samples of diabetic individuals. Methods and Material: Nine different dilutions of methanolic bark and leaf extracts were tested for this purpose in agar well diffusion method. Results: Both the extracts were active against Gram positive as well as Gram negative strains. Zones of inhibition produced by different bacteria for different concentrations were summarized by linear regression. Highest activities were exhibited for coagulase negative Staphylococcus (CONS) by both bark and leaf extracts, Y = 16.95 + 0.19X and Y = 18.90 – 0.70X, respectively. Conclusions: Results indicate that exhaustive studies involving identification of specific compounds in neem extracts and testing their activities in diabetic samples would be worthwhile considering steep emergence of multidrug resistant species in diabetic infections and infections in general.
References
2. Biswas K, Chattopadhyay I, Banerjee RK, Bandyopadhyay U. Biological activities and medicinal properties of neem (Azadirachta indica). Curr Sci. 2002; 82: 1336- 45.
3. Wolinsky LE, Mania S, Nachnani S, Ling S. The inhibiting effect of aqueous Azadirachta indica (neem) extract upon bacterial properties influencing in vitro plaque formation. J Dent Res. 1996; 75: 816-22.
4. Okemo PO, Mwatha WE, Chhabra SC, Fabry W. The kill kinetics of Azadirachta indica A. Juss (Meliaceae) extracts on Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Candida albicans. Afr J Sci Technol. 2001; 2: 113-8.
5. Helmy WA, Amer H, EL- Shayeb NMA. Biological and anti- microbial activities of
aqueous extracts from neem tree (Azadirachta indica A Juss, Meliaceae). J Appl Sci Res. 2007; 3: 1050-5.
6. Huang CR, Lu CH, Chang HW, Lee PY, Lin MW, Chang WN. Community- acquired spontaneous bacterial meningitis in adult diabetic patients: an analysis of clinical characteristics and prognosis factors. Infection 2002; 30: 346-50.
7. Bansal E, Garg A, Bhatia S, Attri AK, Chander J. Spectrum of microbial flora in diabetic foot ulcers. Indian J Pathol Microbiol. 2008; 51: 204-8.
8. Colle JG, Duguid JP, Fraser AG, Marmion BP, Simon A. Laboratory strategy in the diagnosis of infective syndrome. In: Colle JG, Fraser AG, Marmion BP, Simon A (Editors). Mackie and McCartney. Practical Medical Microbiology 14th ed. London: Churchill Livingstone 1996; p.84-90.
9. Armstrong DG, Lipsky BA. Diabetic foot infections: stepwise medical and surgical management. Int Wound J. 2004; 1: 123-32.
10. Sharma VK, Khadka PB, Joshi A, Sharma R. Common pathogens isolated in diabetic foot infection in Bir Hospital. Kathmandu Univ Med J. 2006; 4: 295-301.
11. Sun Y, Dowel SE, Smith E, Rhoads DD, Wolcott RD. In vitro multispecies Lubbock chronic woundbiofilm model. Wound Repair Regen. 2008; 16: 805-13.
12. Sharma D, Lavania AA, Sharma A. In vitro comparative screening of antibacterial and antifungal activities of some common plants and weeds extracts. Asian J Exp Sci. 2009; 23: 169-72.
13. Fabry W, Okemo PO, Ansorg R. Antibacterial activity of East African medicinal plants. J Ethnopharmacol. 1998; 60: 79-84.
14. Galkowska H, Podbielska A, Olszewski WL, Stelmach E, Luczak M, Rosinski G, Karnafel W. Epidemiology and prevalence of methicillin- resistant Staphylococcus aureus and Staphylococcus epidermidis in patients with diabetic foot ulcers: focus on the differences between species isolated for individuals with ischemic vs. neuropathic foor ulcers. Diabetes Res Clin Pract. 2009; 84: 187-93.
15. Varaiya A, Kulkarni M, Bhalekar P, Dogra J. Incidence of metallo- beta- lactamase- producing Pseudomonas aeruginosa in diabetes and cancer patients. Indian J of Pathol Microbiol. 2008; 51: 200-3.
